Effects of postmenopausal estrogen/progestin replacement therapy on LDL particles; comparison of transdermal and oral treatment regimens.

[1]  Susan R. Johnson,et al.  Effects of Estrogen or Estrogen/ Progestin Regimens on Heart Disease Risk Factors in Postmenopausal Women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial , 1995 .

[2]  F. Sacks,et al.  Sex hormones and lipoprotein metabolism. , 1994, Current opinion in lipidology.

[3]  C. Packard,et al.  Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk. , 1994, Atherosclerosis.

[4]  Y. Min,et al.  Effects of hormone replacement therapy on lipoprotein(a) and lipids in postmenopausal women. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[5]  M. Seed,et al.  Post-menopausal hormone replacement therapy, coronary heart disease and plasma lipoproteins. , 1994, Current opinion in lipidology.

[6]  J. Larosa,et al.  Quantitative and qualitative changes in lipids, lipoproteins, apolipoprotein A‐I, and sex hormone‐binding globulin due to two doses of conjugated equine estrogen with and without a progestin , 1994, Obstetrics and gynecology.

[7]  S. Adami,et al.  Long-term effects of transdermal and oral estrogens on serum lipids and lipoproteins in postmenopausal women. , 1993, Maturitas.

[8]  M. Klag,et al.  Plasma lipoprotein levels as predictors of cardiovascular death in women. , 1993, Archives of internal medicine.

[9]  B. Griffin,et al.  Response of plasma low density lipoprotein subfractions to oestrogen replacement therapy following surgical menopause , 1993, Clinical endocrinology.

[10]  R. Krauss,et al.  Differential effects of estrogen on low-density lipoprotein subclasses in healthy postmenopausal women. , 1993, Metabolism: clinical and experimental.

[11]  L. Speroff,et al.  A Comparison of Esterified Estrogens With and Without Methyltestosterone: Effects on Endometrial Histology and Serum Lipoproteins in Postmenopausal Women , 1993, Obstetrics and gynecology.

[12]  A. Aydinlar,et al.  Effect of progestogens on estrogen-induced lipoprotein changes. , 1993, European journal of obstetrics, gynecology, and reproductive biology.

[13]  M. Taskinen,et al.  Effects of Gemfibrozil on Low-Density Lipoprotein Particle Size, Density Distribution, and Composition in Patients With Type II Diabetes , 1993, Diabetes Care.

[14]  P. Durrington,et al.  Increased transfer of cholesteryl esters from high density lipoproteins to low density and very low density lipoproteins in patients with angiographic evidence of coronary artery disease. , 1993, Atherosclerosis.

[15]  J. Ordovás,et al.  Effects of estrogen replacement on plasma lipoproteins and apolipoproteins in postmenopausal, dyslipidemic women. , 1992, Metabolism: clinical and experimental.

[16]  E. Eaker,et al.  The risk of acute myocardial infarction after oestrogen and oestrogen‐progestogen replacement , 1992, British journal of obstetrics and gynaecology.

[17]  A. Bostom,et al.  Postmenopausal estrogen therapy and cardiovascular disease. , 1992, The New England journal of medicine.

[18]  R. Lobo,et al.  Clinical review 27: Effects of hormonal replacement on lipids and lipoproteins in postmenopausal women. , 1991, The Journal of clinical endocrinology and metabolism.

[19]  B. Rosner,et al.  Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. , 1991, The New England journal of medicine.

[20]  J. Manson,et al.  Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study. , 1991, The New England journal of medicine.

[21]  B. Henderson,et al.  Decreased Mortality in Users of Estrogen Replacement Therapy , 1991, Archives of internal medicine.

[22]  E. Barrett-Connor,et al.  Estrogen and coronary heart disease in women , 1991, JAMA.

[23]  P. Wilson,et al.  Differences in apolipoproteins and low-density lipoprotein subfractions in postmenopausal women on and off estrogen therapy: results from the Framingham Offspring Study. , 1990, Metabolism: clinical and experimental.

[24]  M. Whitehead,et al.  The Role and Use of Progestogens , 1990, Obstetrics and gynecology.

[25]  E. Guzman,et al.  A quantitative analysis of placental vasculature in the third‐trimester fetus with autosomal trisomy , 1990, Obstetrics and gynecology.

[26]  M. King,et al.  Inheritance of low-density lipoprotein subclass patterns: results of complex segregation analysis. , 1988, American journal of human genetics.

[27]  W C Willett,et al.  Low-density lipoprotein subclass patterns and risk of myocardial infarction. , 1988, JAMA.

[28]  P. Wilson,et al.  Differences in low density lipoprotein subfractions and apolipoproteins in premenopausal and postmenopausal women. , 1988, The Journal of clinical endocrinology and metabolism.

[29]  P. Wilson,et al.  Effect of Gender, Age, and Lipid Status on Low Density Lipoprotein Su bf raction Distribution: Results from the Framingham Offspring Study , 1987, Arteriosclerosis.

[30]  E. Barrett-Connor,et al.  Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. , 1987, Circulation.

[31]  C. Fletcher,et al.  Lipoprotein and apoprotein levels in postmenopausal women during treatment with norethisterone. , 1986, Clinica chimica acta; international journal of clinical chemistry.

[32]  T. Lövgren,et al.  Europium as a label in time-resolved immunofluorometric assays. , 1984, Analytical biochemistry.

[33]  L. Wallentin,et al.  L‐norgestrel and progesterone have different influences on plasma lipoproteins , 1983, European journal of clinical investigation.

[34]  R. Mertens,et al.  Evaluation of a radioimmunoassay for estradiol in unextracted serum. , 1983, Clinical chemistry.

[35]  W. Fisher.  Heterogeneity of plasma low density lipoproteins manifestations of the physiologic phenomenon in man. , 1983, Metabolism: clinical and experimental.

[36]  G. J. Jones,et al.  Decreased Plasma Phosphatidylcholine/Free Cholesterol Ratio as an Indicator of Risk for Ischemic Vascular Disease , 1982, Arteriosclerosis.

[37]  V. Manninen,et al.  Effects of Different Progestogens on Lipoproteins during Postmenopausal Replacement Therapy , 1981 .

[38]  Y. Chao,et al.  The estradiol-stimulated lipoprotein receptor of rat liver. A binding site that membrane mediates the uptake of rat lipoproteins containing apoproteins B and E. , 1980, The Journal of biological chemistry.

[39]  M. Kashyap,et al.  A rapid and simple method for measurement of total protein in very low density lipoproteins by the Lowry assay. , 1980, Journal of lipid research.

[40]  L. Wilkins.  Plasma Lipid Distributions in Selected North American Populations: The Lipid Research Clinics Program Prevalence Study THE LIPID RESEARCH CLINICS PROGRAM EPIDEMIOLOGY COMMITTEE , 1979, Circulation.

[41]  P. Kinnunen,et al.  An immunochemical method for the selective measurement of two triglyceride lipases in human postheparin plasma. , 1975, Clinica chimica acta; international journal of clinical chemistry.

[42]  J. Margolis,et al.  Electrophoresis in polyacrylamide concentration gradient. , 1967, Biochemical and biophysical research communications.

[43]  R. Havel,et al.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. , 1955, The Journal of clinical investigation.

[44]  R. Krauss,et al.  Identification of multiple subclasses of plasma low density lipoproteins in normal humans. , 1982, Journal of lipid research.